Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
Featured trial
A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

  • 658 views
  • 08 Nov, 2020
  • 5 locations
None
Trabectedin for Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

The objective of this study is to facilitate access to trabectedin for eligible previously treated subjects with soft tissue sarcoma (STS), who cannot be expected to benefit from

metastatic soft tissue sarcoma
trabectedin
soft tissue sarcoma
  • 60 views
  • 07 Nov, 2020
  • 1 location
None
Study With Trabectedin Versus Adriamycin Plus Dacarbazine in Patients With Advanced Solitary Fibrous Tumor

Phase II randomized study for the comparison of trabectedin versus doxorubicin plus dacarbazine in patients with advanced solitary fibrous tumor

  • 31 views
  • 24 Jan, 2021
  • 4 locations
None
SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients

This study evaluates the trabectedin and irinotecan in the treatment of Ewings sarcoma, with a EWS-FLI1 mutation. Patients will also receive an infusion of 18F-FLT in combination with a Positron

measurable disease
refractory ewing sarcoma
irinotecan
  • 0 views
  • 12 May, 2021
  • 4 locations
None
Randomized Trial in Advanced Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.

Phase II study in patient with advanced Soft Tissue Sarcoma (STS) patients who have already received or are not suitable, for a doxorubicin-based treatment.

  • 0 views
  • 23 May, 2021
  • 15 locations
None
Reprab Study: PLD + Trabectedin Rechallenge

RECHALLENGE WITH PEGYLATED LIPOSOMAL DOXORUBICIN ADDED TO TRABECTEDIN IN RECURRENT OVARIAN CANCER: A MULTICENTER, PROSPECTIVE TRIAL

  • 0 views
  • 19 Aug, 2021
  • 1 location
None
Metronomic Trabectedin Gemcitabine and Dacarbazine for Leiomyosarcoma

This is an open label phase 2 study using metronomic doses of trabectedin, gemcitabine and dacarbazine given intravenously.

platelet count
gemcitabine
dacarbazine
leiomyosarcoma
kidney function tests
  • 0 views
  • 24 Sep, 2021
  • 1 location
None
Talimogene Laherparepvec Nivolumab and Trabectedin for Sarcoma

This is a Phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin as first, second or third line therapy for advanced sarcoma, including desmoid tumor and chordoma.

platelet count
advanced sarcoma
metastatic sarcoma
kidney function tests
measurable disease
  • 1 views
  • 26 Aug, 2021
  • 1 location
None
Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin

This trial compares trabectedin alone to trabectedin in combination with regional hyperthermia in patients with high-risk soft tissue sarcoma. The study is designed to demonstrate a significant

soft tissue sarcoma
anthracyclines
trabectedin
neutrophil count
ewing's sarcoma
  • 82 views
  • 22 Jan, 2021
  • 7 locations
None
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients

Phase I-II trial that combines trabectedin plus radiotherapy for tumor reduction response measure in two cohorts of patients: Cohort A: Patients with diagnosis of non-operable or

malignant peripheral nerve sheath tumor
leiomyosarcoma
synovial sarcoma
liposarcoma
mpnst
  • 25 views
  • 24 Jan, 2021
  • 21 locations